A Chemotherapeutic and Biospectroscopic Investigation of the Interaction of Double Standard DNA/RNA Binding Molecules with Cadmium Oxide (CdO) and Rhodium (III) Oxide (Rh2O3) Nanoparticles as Anti Cancer Drugs for Cancer Cells Treatment
Faculty of Chemistry, California South University, 14731 Comet St. Irvine, CA 92604, USA
- *Corresponding Author:
- Heidari A
Faculty of Chemistry, California South University
14731 Comet St. Irvine, CA 92604, USA
E-mail: [email protected]
Received date: April 28, 2016; Accepted date: April 28, 2016; Published date: May 02, 2016
Citation: Heidari A (2016) A Chemotherapeutic and Biospectroscopic Investigation of the Interaction of Double–Standard DNA/RNA–Binding Molecules with Cadmium Oxide (CdO) and Rhodium (III) Oxide (Rh2O3) Nanoparticles as Anti–Cancer Drugs for Cancer Cells’ Treatment. Chemo Open Access 5: e129. doi:10.4172/2167-7700.1000e129
Copyright: © 2016 Heidari A. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Chemotherapists have been fascinated for a long time with phenomenon of anti–cancer drugs. This editorial generally associated with anti-cancer compounds, now extends equally well to medicinal and pharmaceutical chemistry . Despite this continuing very frequent use in the scientific literature, anti–cancer drugs like many other and useful and popular chemical concepts is non–reductive and lacks an unambiguous basis. It has no precise quantitative definition and is not directly measureable experimentally. In other words, anti– cancer compounds are a virtual quantity, rather than a physical observable. Hence, the chemistry of anti–cancer drugs has been attractive to chemotherapists. In addition, the interest to the chemistry of nanoparticles is due to the fact that nanoparticles are important synthetic materials in the preparation of anti–cancer compounds.